Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Low |
The actual benefit of BRONCHITOL is low. |
Clinical Added Value
| no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis. |
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
14v6S2Y27wuG6PdL
Listen
